N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide

CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C

InChI=1S/C18H28N2O4/c1-5-6-18(23)20-14-7-8-17(16(9-14)13(4)21)24-11-15(22)10-19-12(2)3/h7-9,12,15,19,22H,5-6,10-11H2,1-4H3,(H,20,23)

GOEMGAFJFRBGGG-UHFFFAOYSA-N

acebutolol; 37517-30-9; Acetobutolol; dl-Acebutolol; Neptal; Acebutololo; Sectral; Acebutololum; (+-)-Acebutolol; N-(3-Acetyl-4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)butyramide; 5'-Butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone; CHEBI:2379; C07AB04; N-(3-acetyl-4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)butanamide; 3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; 1-(2-Acetyl-4-n-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane; N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide; N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide; 67P356D8GH; N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide; Acebrutololum; Monitan; N-{3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}butanamide; Acebutololum [INN-Latin]; Acebrutololum [INN-Latin]; Acetobutolol [INN-Spanish]; Acebutolol [USAN:INN:BAN]; Butanamide, N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]-; Butanamide, N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]-, (.+/-.)-; (+/-)-acebutolol; CCRIS 9214; RP 21823; Acebutolol (USAN/INN); EINECS 253-539-0; BRN 2162244; UNII-67P356D8GH; 3'-Acetyl-4'-(2-hydroxy-3-isopropylaminopropoxy)butyranilid; 3'-(Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; (+-)-3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; (+-)-N-(3-Acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)butanamide; Sectral (Salt/Mix); Wesfalin (Salt/Mix); Spectrum_000491; ACEBUTOLOL [MI]; ACEBUTOLOL [INN]; Prestwick0_000069; Prestwick1_000069; Prestwick2_000069; Prestwick3_000069; Spectrum2_001340; Spectrum3_000573; Spectrum4_000802; Spectrum5_001399; (.+/-.)-Acebutolol; ACEBUTOLOL [USAN]; ACEBUTOLOL [VANDF]; CHEMBL642; Epitope ID:146105; ACEBUTOLOL [MART.]; SCHEMBL3772; ACEBUTOLOL [WHO-DD]; Butanamide, N-(3-acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)-, (+-)-; BSPBio_000257; BSPBio_001986; KBioGR_001283; KBioSS_000971; DivK1c_000612; SPBio_001499; SPBio_002178; BPBio1_000283; GTPL7107; IL 17803A (Salt/Mix); Discontinued. See: A123800; DTXSID2048539; BDBM25755; KBio1_000612; KBio2_000971; KBio2_003539; KBio2_006107; KBio3_001486; NINDS_000612; MFCD00599435; AKOS015963037; DB01193; DS-3129; IDI1_000612; NCGC00018215-02; HY-17497; SBI-0051584.P003; DB-069556; AB00053574; CS-0009240; FT-0660954; C06803; D02338; AB00053574_13; AB00053574_14; EN300-7398930; 197A639; A935714; L000998; Q418857; BRD-A29260609-003-05-4; BRD-A29260609-003-15-3; 1-[2-Acetyl-4-(butyrylamino)phenoxy]-3-(isopropylamino)-2-propanol; (.+/-.)-3'-Acetyl-4'-[2-hydroxy-3-(isopropylamino)propoxy]butyranilide; N-(3-Acetyl-4-(2-hydroxy-3-(isopropylamino)-propoxy)phenyl)butyramide; N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide #; N-[3-Acetyl-4-(2-hydroxy-3-propan-2-ylaminopropoxy)-phenyl] butanamide; (+/-)-3'-ACETYL-4'-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)BUTYRANILIDE; (.+/-.)-3'-Acetyl-4'-[2-hydroxy-3-(1-methylethylamino)propoxy]butyranilide; (.+/-.)-N-(3-Acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)butanamide; N-(3-acetyl-4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)butanimidic acid; 28197-63-9; BUTANAMIDE, N-(3-ACETYL-4-(2-HYDROXY-3-((1-METHYLETHYL)AMINO)PROPOXY)PHENYL)-, (+/-)-; Butanamide, N-(3-acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)-,monohydrochloride,(+-)-